Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Pugliese

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Future Medicinal Chemistry|October 24, 2012
Computational tools and resources for metabolism-related property predictions. 2. Application to prediction of half-life time in human liver microsomesAlexey V Zakharov, Megan L Peach, Markus Sitzmann, et al.
International Journal of Cancer|September 4, 2008
The resveratrol analogue 3,5,3',4',5'-pentahydroxy-trans-stilbene inhibits cell transformation via MEKKi Won Lee, Nam Joo Kang, Evgeny A Rogozin, et al.
Cancer Research|June 18, 2009
[6]-Gingerol suppresses colon cancer growth by targeting leukotriene A4 hydrolaseChul-Ho Jeong, Ann M Bode, Angelo Pugliese, et al.
Neoplasia (New York, N.Y.)|October 18, 2015
Identification of a Selective G1-Phase Benzimidazolone Inhibitor by a Senescence-Targeted Virtual Screen Using Artificial Neural NetworksAlan E Bilsland, Angelo Pugliese, Yu Liu, et al.
Cancer Research|February 5, 2008
Raf and MEK protein kinases are direct molecular targets for the chemopreventive effect of quercetin, a major flavonol in red wineKi Won Lee, Nam Joo Kang, Yong-Seok Heo, et al.
The Journal of Biological Chemistry|November 25, 2010
Eriodictyol inhibits RSK2-ATF1 signaling and suppresses EGF-induced neoplastic cell transformationKangdong Liu, Yong-Yeon Cho, Ke Yao, et al.
Drug Discovery Today|August 3, 2013
Fragment-based hit identification: thinking in 3DAndrew D Morley, Angelo Pugliese, Kristian Birchall, et al.
Journal of Medicinal Chemistry|February 2, 2022
Stabilization of the RAS:PDE6D Complex Is a Novel Strategy to Inhibit RAS SignalingTamas Yelland, Esther Garcia, Charles Parry, et al.
Bioorganic & Medicinal Chemistry Letters|February 19, 2019
Structure-based design, synthesis and biological evaluation of a novel series of isoquinolone and pyrazolo[4,3-c]pyridine inhibitors of fascin 1 as potential anti-metastatic agentsStuart Francis, Daniel Croft, Alexander W Schüttelkopf, et al.
Bioorganic & Medicinal Chemistry Letters|December 23, 2023
Discovery and characterization of novel TRPML1 agonistsXiaowen Peng, Christopher J Holler, Anna-Maria F Alves, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Future Medicinal Chemistry|October 24, 2012
Computational tools and resources for metabolism-related property predictions. 2. Application to prediction of half-life time in human liver microsomesAlexey V Zakharov, Megan L Peach, Markus Sitzmann, et al.
International Journal of Cancer|September 4, 2008
The resveratrol analogue 3,5,3',4',5'-pentahydroxy-trans-stilbene inhibits cell transformation via MEKKi Won Lee, Nam Joo Kang, Evgeny A Rogozin, et al.
Cancer Research|June 18, 2009
[6]-Gingerol suppresses colon cancer growth by targeting leukotriene A4 hydrolaseChul-Ho Jeong, Ann M Bode, Angelo Pugliese, et al.
Neoplasia (New York, N.Y.)|October 18, 2015
Identification of a Selective G1-Phase Benzimidazolone Inhibitor by a Senescence-Targeted Virtual Screen Using Artificial Neural NetworksAlan E Bilsland, Angelo Pugliese, Yu Liu, et al.
Cancer Research|February 5, 2008
Raf and MEK protein kinases are direct molecular targets for the chemopreventive effect of quercetin, a major flavonol in red wineKi Won Lee, Nam Joo Kang, Yong-Seok Heo, et al.
The Journal of Biological Chemistry|November 25, 2010
Eriodictyol inhibits RSK2-ATF1 signaling and suppresses EGF-induced neoplastic cell transformationKangdong Liu, Yong-Yeon Cho, Ke Yao, et al.
Drug Discovery Today|August 3, 2013
Fragment-based hit identification: thinking in 3DAndrew D Morley, Angelo Pugliese, Kristian Birchall, et al.
Journal of Medicinal Chemistry|February 2, 2022
Stabilization of the RAS:PDE6D Complex Is a Novel Strategy to Inhibit RAS SignalingTamas Yelland, Esther Garcia, Charles Parry, et al.
Bioorganic & Medicinal Chemistry Letters|February 19, 2019
Structure-based design, synthesis and biological evaluation of a novel series of isoquinolone and pyrazolo[4,3-c]pyridine inhibitors of fascin 1 as potential anti-metastatic agentsStuart Francis, Daniel Croft, Alexander W Schüttelkopf, et al.
Bioorganic & Medicinal Chemistry Letters|December 23, 2023
Discovery and characterization of novel TRPML1 agonistsXiaowen Peng, Christopher J Holler, Anna-Maria F Alves, et al.
Pageof 3